Skip to main content
Caplight Logo









Domus Diagnostics

Domus Diagnostics

Private
Park City, UtahHealthcare & Life Scienceshttps://www.domusdx.com/

Last Round

Grant

May 24, 2023

Total Funding Raised

$3.9M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Domus Diagnostics is a diagnostic equipment company that develops affordable, user-friendly, and rapid at-home and point-of-care molecular diagnostic tests for infectious diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

nucleic acid amplification testingNAATmolecular diagnosticspoint of care testingPOCTRT-LAMPat-home diagnosticrapid testinginfectious disease testinginstrument-free diagnosticsdisposable test kitPCR-accurateglobal health diagnosticslow-cost diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Domus Diagnostics Comparables

Compare Domus Diagnostics with similar companies based on industry and business-model similarity.

Domus Diagnostics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Seek Labs
78%
Llusern Scientific
77%
OraSure Technologies Inc
77%

Domus Diagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 24, 2023
SeedApr 20, 2022

Domus Diagnostics Investors

Notable investors and investment history

Domus Diagnostics investors
InvestorRounds
National Institute of Biomedical Imaging and BioengineeringGrant
NIH RADxGrant
Bantam GroupSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 49% MoM, reaching 1.6K.

  • Jul 25, 2026

    Monthly visitors grew 296% MoM, reaching 1.1K.

Domus Diagnostics Filings

Explore SEC and related filing metadata, where available.

Domus Diagnostics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Domus Diagnostics's valuation, stock price, and market status.

Is Domus Diagnostics a public or private company?

Domus Diagnostics is a private company.

What is the current stock price of Domus Diagnostics?

Domus Diagnostics is a private company with no public stock price. No recent secondary market data is available.

How much is Domus Diagnostics worth (valuation)?

Valuation information for Domus Diagnostics is not publicly available.

Can I buy Domus Diagnostics stock?

Domus Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Domus Diagnostics's last funding round?

Domus Diagnostics's most recent funding round was Grant on May 24, 2023.

Who are the main investors in Domus Diagnostics?

Key investors in Domus Diagnostics include National Institute of Biomedical Imaging and Bioengineering, NIH RADx, Bantam Group.

Will Domus Diagnostics IPO soon?

No public IPO plans have been announced for Domus Diagnostics.

How can I track Domus Diagnostics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Domus Diagnostics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPark City, Utah
Employee Range1
Year Founded2021
Last FundingMay 24, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?